Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
650 Pleasant Street , Watertown, MA, 02472, US
ReciBioPharm, a division of Recipharm, is a CDMO specifically focused on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs). ReciBioPharm’s specialized capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Addressing increasing complexity, cost of drug development, and navigating regulatory compliance.
By: Kristin Brooks
Industry experts weigh in on current trends, challenges, and the future of the cell and gene therapy CDMO market.
By: Charlie Sternberg
ATP-bioluminescence and regulatory advancements address unmet manufacturing and testing needs.
By: Brice Chasey
How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and patient access?
By: Dr. Diego Correa, Erin Finot
Cryoport Systems is transforming the advanced therapies supply chain with integrated services that support every stage of development from early clinical to commercial scale.
Released By Cryoport Systems
Aim to support the advancement of cutting-edge cell therapies.
Gains Halo’s Aura platform, a highly differentiated technology that performs full spectrum particle analysis.
A key focus of the partnership will be the development of adeno-associated virus (AAV) gene therapy programs using intellectual property from KU Leuven.
Nelson Labs Nina Moreno shares insight on rapid sterility testing, the technologies used, advantages, and regulatory considerations.
Released By Nelson Laboratories, LLC
Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines to develop and manufacture AAV Therapeutics.
By: Rachel Klemovitch
The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.
For this roundtable, Contract Pharma called upon thought leaders across the pharmaceutical services sector to address “3 Key Trends” impacting the CDMO industry in 2025 and beyond.
By: Tim Wright
Aim to create a seamless, powerful ecosystem that reduces costly barriers for CGT innovators.
An integrated supply chain partner can reduce risk, enable scalability, and preserve capital in today’s volatile market.
Enhances SK pharmteco’s position as a key partner in advancing the CGT landscape.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
